• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图作为肥厚型心肌病患儿心肌瘢痕的筛查试验

Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.

作者信息

Compton Gregory, Nield Lynne, Dragulescu Andreea, Benson Lee, Grosse-Wortmann Lars

机构信息

Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada.

Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada.

出版信息

Int J Pediatr. 2016;2016:1980636. doi: 10.1155/2016/1980636. Epub 2016 Nov 15.

DOI:10.1155/2016/1980636
PMID:27974896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5126423/
Abstract

. Hypertrophic cardiomyopathy (HCM) is burdened with morbidity and mortality including tachyarrhythmias and sudden cardiac death. These complications are attributed in part to the formation of proarrhythmic scars in the myocardium. The presence of extensive LGE is a risk factor for adverse outcomes in HCM. Late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (cMRI) is the standard for the noninvasive evaluation of myocardial scars. However, echocardiography represents an attractive screening tool for myocardial scarring. The aim of this study was to compare the suitability of echocardiography to detect myocardial scars to the standard of cMRI-LGE. . The cMRI studies and echocardiograms from 56 consecutive children with HCM were independently evaluated for the presence of cMRI-LGE and echocardiographic evidence of scarring by expert readers. . Echocardiography had a high sensitivity (93%) and negative predictive value (94%) in comparison to LGE. The false positive rate was high, leading to a low specificity (37%) and a low positive predictive value (35%). . Given the poor specificity and positive predictive value, echocardiography is not a suitable screening test for the presence of myocardial scarring in children with HCM. However, children without echocardiographic evidence of myocardial scarring may not need to undergo cardiac magnetic resonance imaging to "rule in" LGE.

摘要

肥厚型心肌病(HCM)存在包括快速性心律失常和心源性猝死在内的发病和死亡负担。这些并发症部分归因于心肌中促心律失常瘢痕的形成。广泛的延迟强化(LGE)的存在是HCM不良结局的一个危险因素。钆延迟增强(LGE)心脏磁共振成像(cMRI)是心肌瘢痕无创评估的标准。然而,超声心动图是一种有吸引力的心肌瘢痕筛查工具。本研究的目的是比较超声心动图检测心肌瘢痕的适用性与cMRI-LGE标准。对连续56例HCM患儿的cMRI研究和超声心动图进行独立评估,由专业人员判断是否存在cMRI-LGE及瘢痕形成的超声心动图证据。与LGE相比,超声心动图具有较高的敏感性(93%)和阴性预测值(94%)。假阳性率较高,导致特异性较低(37%)和阳性预测值较低(35%)。鉴于特异性和阳性预测值较差,超声心动图不是HCM患儿心肌瘢痕存在与否的合适筛查试验。然而,没有超声心动图心肌瘢痕证据的儿童可能无需进行心脏磁共振成像来“确诊”LGE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/31a7cd18ee35/IJPEDI2016-1980636.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/a95f76c8f2a7/IJPEDI2016-1980636.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/e0b7e090af1d/IJPEDI2016-1980636.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/b8ec133c70ba/IJPEDI2016-1980636.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/31a7cd18ee35/IJPEDI2016-1980636.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/a95f76c8f2a7/IJPEDI2016-1980636.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/e0b7e090af1d/IJPEDI2016-1980636.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/b8ec133c70ba/IJPEDI2016-1980636.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4de/5126423/31a7cd18ee35/IJPEDI2016-1980636.004.jpg

相似文献

1
Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.超声心动图作为肥厚型心肌病患儿心肌瘢痕的筛查试验
Int J Pediatr. 2016;2016:1980636. doi: 10.1155/2016/1980636. Epub 2016 Nov 15.
2
Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing.基于Panel-Wide Sequencing 的晚期钆增强预测突变阳性肥厚型心肌病。
Circ J. 2018 Mar 23;82(4):1139-1148. doi: 10.1253/circj.CJ-17-1012. Epub 2018 Feb 3.
3
Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.肥厚型心肌病患儿及青少年中肥厚与延迟钆增强的分布情况
Congenit Heart Dis. 2015 Nov-Dec;10(6):E258-67. doi: 10.1111/chd.12286. Epub 2015 Jul 20.
4
Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者心脏磁共振钆延迟增强的预后意义。
Heart Lung. 2018 Mar-Apr;47(2):122-126. doi: 10.1016/j.hrtlng.2017.10.008. Epub 2017 Nov 22.
5
Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.与T1 mapping相比,定量扩散加权磁共振成像在肥厚型心肌病心肌纤维化评估中的应用
Int J Cardiovasc Imaging. 2016 Aug;32(8):1289-97. doi: 10.1007/s10554-016-0909-x. Epub 2016 May 19.
6
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.晚期钆增强在肥厚型心肌病临床结局中的预测价值。
JACC Cardiovasc Imaging. 2012 Apr;5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021.
7
Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.用于检测小儿肥厚型心肌病中心肌纤维化的新型心脏磁共振特征追踪(CMR-FT)分析
Pediatr Cardiol. 2016 Apr;37(4):663-73. doi: 10.1007/s00246-015-1329-8. Epub 2016 Jan 30.
8
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
9
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
10
[Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].[2014年欧洲指南心脏性猝死风险预测模型(HCM Risk-SCD)对中国肥厚型心肌病患者的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1033-1038. doi: 10.3760/cma.j.issn.0253-3758.2017.12.006.

引用本文的文献

1
Cardiac Hypertrophy: A Comprehensive Review from Prenatal Life to Young Adulthood.心脏肥大:从胎儿期到青年期的全面综述
Children (Basel). 2025 Jul 28;12(8):989. doi: 10.3390/children12080989.
2
Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.机器学习对肥厚型心肌病电影中的瘢痕心肌进行表型分析。
Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):532-542. doi: 10.1093/ehjci/jeab056.
3
The value of fragmented QRS in predicting the prognosis of chronic total occlusion patients with myocardial infarction history undergoing percutaneous coronary intervention: A 24-months follow-up study.

本文引用的文献

1
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
2
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
3
碎裂 QRS 波对伴心肌梗死病史的慢性完全闭塞病变患者行经皮冠状动脉介入治疗后预后预测的价值:一项 24 个月随访研究。
Clin Cardiol. 2021 Apr;44(4):537-546. doi: 10.1002/clc.23573. Epub 2021 Feb 16.
4
Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.减轻心脏纤维化:钠钾ATP酶信号复合体作为一个新靶点
Cardiovasc Pharm Open Access. 2017;6(1). doi: 10.4172/2329-6607.1000204. Epub 2017 Jan 31.
Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
肥厚型心肌病患者年龄<20 岁时钆延迟增强的临床意义。
Am J Cardiol. 2014 Apr 1;113(7):1234-9. doi: 10.1016/j.amjcard.2013.12.034. Epub 2014 Jan 15.
4
Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.肥厚型心肌病患儿的心血管磁共振特征。
Circ Heart Fail. 2013 Sep 1;6(5):1013-20. doi: 10.1161/CIRCHEARTFAILURE.113.000414. Epub 2013 Jul 19.
5
Update on ultrasound imaging of liver fibrosis.肝纤维化的超声成像进展
J Hepatol. 2013 Jul;59(1):180-2. doi: 10.1016/j.jhep.2012.12.028. Epub 2013 Jan 15.
6
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.肥厚型心肌病:诊断、风险分层与治疗
CMAJ. 2013 Feb 5;185(2):127-34. doi: 10.1503/cmaj.120138. Epub 2012 Oct 29.
7
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告。与美国胸外科协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、心血管造影和介入学会以及胸外科医师学会合作制定。
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.
8
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):e783-831. doi: 10.1161/CIR.0b013e318223e2bd. Epub 2011 Nov 8.
9
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.心肌纤维化作为肥厚型心肌病的早期表现。
N Engl J Med. 2010 Aug 5;363(6):552-63. doi: 10.1056/NEJMoa1002659.
10
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.心肌纤维化在肥厚型心肌病中的预后意义。
J Am Coll Cardiol. 2010 Sep 7;56(11):867-74. doi: 10.1016/j.jacc.2010.05.010. Epub 2010 Jun 25.